Jaffe Food Allergy Institute, Immunology Institute, Mindich Child Health Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Pediatrics, Icahn School of Medicine at Mount Sinai, Box 1198, One Gustave L. Levy Place, New York, NY, 10029, USA.
Clin Rev Allergy Immunol. 2018 Oct;55(2):107-117. doi: 10.1007/s12016-018-8680-5.
Oral tolerance is a state of systemic unresponsiveness that is the default response to food antigens in the gastrointestinal tract, although immune tolerance can also be induced by other routes, such as the skin or inhalation. Antigen can be acquired directly by intestinal phagocytes, or pass through enterocytes or goblet cell-associated passages prior to capture by dendritic cells (DCs) in the lamina propria. Mucin from goblet cells acts on DCs to render them more tolerogenic. A subset of regulatory DCs expressing CD103 is responsible for delivery of antigen to the draining lymph node and induction of Tregs. These DCs also imprint gastrointestinal homing capacity, allowing the recently primed Tregs to home back to the lamina propria where they interact with macrophages that produce IL-10 and expand. Tregs induced by dietary antigen include Foxp3 Tregs and Foxp3 Tregs. In addition to Tregs, T cell anergy can also contribute to oral tolerance. The microbiota plays a key role in the development of oral tolerance, through regulation of macrophages and innate lymphoid cells that contribute to the regulatory phenotype of gastrointestinal dendritic cells. Absence of microbiota is associated with a susceptibility to food allergy, while presence of Clostridia strains can suppress development of food allergy through enhancement of Tregs and intestinal barrier function. It is not clear if feeding of antigens can also induce true immune tolerance after a memory immune response has been generated, but mechanistic studies of oral immunotherapy trials demonstrate shared pathways in oral tolerance and oral immunotherapy, with a role for Tregs and anergy. An important role for IgA and IgG antibodies in development of immune tolerance is also supported by studies of oral tolerance in humans. The elucidation of key pathways in oral tolerance could identify new strategies to increase efficacy of immunotherapy treatments for food allergy.
口服耐受是一种全身无反应状态,是肠道中食物抗原的默认反应,尽管免疫耐受也可以通过其他途径诱导,如皮肤或吸入。抗原可以被肠道吞噬细胞直接摄取,也可以通过肠上皮细胞或杯状细胞相关途径摄取,然后被固有层中的树突状细胞(DC)捕获。杯状细胞的粘蛋白作用于 DC,使它们更具耐受性。表达 CD103 的调节性 DC 亚群负责将抗原递送至引流淋巴结,并诱导 Tregs。这些 DC 还赋予了胃肠道归巢能力,使最近被激活的 Tregs 归巢到固有层,在那里与产生 IL-10 并扩增的巨噬细胞相互作用。膳食抗原诱导的 Tregs 包括 Foxp3 Tregs 和 Foxp3 Tregs。除了 Tregs 之外,T 细胞失能也可能有助于口服耐受。微生物群在口服耐受的发展中起着关键作用,通过调节巨噬细胞和先天淋巴细胞,促进胃肠道树突状细胞的调节表型。微生物群的缺失与食物过敏易感性有关,而梭状芽孢杆菌的存在可以通过增强 Tregs 和肠道屏障功能来抑制食物过敏的发展。目前尚不清楚在产生记忆免疫反应后,抗原的摄入是否也能诱导真正的免疫耐受,但口服免疫治疗试验的机制研究表明,口服耐受和口服免疫治疗有共同的途径,Tregs 和失能起作用。人类口服耐受研究也支持 IgA 和 IgG 抗体在免疫耐受发展中的重要作用。阐明口服耐受的关键途径可能为提高食物过敏免疫治疗的疗效提供新策略。